Profile data is unavailable for this security.
About the company
Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.
- Revenue in CHF (TTM)988.44k
- Net income in CHF14.88m
- Incorporated2013
- Employees17.00
- LocationXlife Sciences AGTalacker 35ZUERICH 8001SwitzerlandCHE
- Phone+41 443858460
- Websitehttps://www.xlifesciences.ch/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Santhera Pharmaceuticals Holding AG | 103.38m | 54.78m | 119.94m | 46.00 | -- | 1.78 | -- | 1.16 | -17.28 | -17.28 | 9.14 | 5.34 | 1.19 | 3.37 | 63.69 | -- | 63.20 | -33.83 | 136.70 | -52.56 | 96.87 | 86.74 | 52.99 | -79.40 | 0.75 | 3.57 | 0.2628 | -- | 1,283.33 | 26.70 | 177.08 | -- | 1.87 | -- |
Molecular Partners AG | 6.73m | -58.53m | 124.17m | 168.00 | -- | 0.6601 | -- | 18.46 | -1.78 | -1.78 | 0.2043 | 5.13 | -- | -- | -- | 40,035.71 | -- | -11.83 | -- | -14.69 | -- | 99.28 | -870.22 | -45.30 | -- | -- | 0.0195 | -- | -96.29 | -7.43 | -152.59 | -- | -1.40 | -- |
Newron Pharmaceuticals SpA | 8.95m | -16.04m | 181.83m | 23.00 | -- | -- | -- | 20.31 | -0.8988 | -0.8988 | 0.5018 | -1.66 | 0.2873 | -- | 4.57 | 389,307.50 | -51.45 | -37.10 | -111.53 | -43.98 | 94.80 | 91.72 | -179.13 | -270.48 | -- | -2.86 | 2.62 | -- | 48.62 | 17.61 | 7.25 | -- | -22.76 | -- |
Xlife Sciences AG | 988.44k | 14.88m | 193.91m | 17.00 | 27.92 | 0.709 | 7.66 | 196.18 | 1.22 | 1.22 | 0.1382 | 47.95 | 0.002 | -- | 0.2044 | 58,143.53 | 1.85 | -- | 2.33 | -- | 45.43 | -- | 938.17 | -- | -- | -- | 0.1345 | -- | -3.85 | -- | 3.96 | -- | -- | -- |
Kuros Biosciences AG | 33.56m | -13.73m | 295.01m | 80.00 | -- | 5.18 | -- | 8.79 | -0.3697 | -0.3697 | 0.9175 | 1.54 | 0.4347 | 2.40 | 7.27 | 419,550.00 | -17.78 | -13.47 | -21.34 | -14.84 | 71.31 | 78.73 | -40.90 | -81.48 | 1.69 | -84.04 | 0.0364 | -- | 86.61 | 115.93 | 5.95 | -- | -13.21 | -- |
Idorsia Ltd | 141.42m | -55.88m | 417.24m | 938.00 | -- | -- | -- | 2.95 | -0.3534 | -0.3534 | 0.7363 | -4.97 | 0.1912 | 0.1645 | 113.09 | 150,766.50 | -7.56 | -46.72 | -12.46 | -53.84 | 93.05 | -- | -39.51 | -709.80 | 1.00 | -26.26 | 5.82 | -- | 56.93 | 20.25 | 64.01 | -- | -8.01 | -- |
Basilea Pharmaceutica AG Allschwil | 157.63m | 10.45m | 581.44m | 147.00 | 50.37 | -- | 48.25 | 3.69 | 0.8765 | 0.8765 | 13.15 | -0.8335 | 0.7999 | 1.06 | 5.16 | 1,072,340.00 | 5.30 | -1.86 | 7.69 | -2.99 | 83.00 | 83.45 | 6.63 | -2.99 | 2.64 | 2.02 | 1.10 | -- | 6.68 | 3.53 | -13.96 | -- | 11.17 | -- |
Data as of May 24 2024. Currency figures normalised to Xlife Sciences AG's reporting currency: Swiss Franc CHF
Holder | Shares | % Held |
---|---|---|
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 31.72k | 0.56% |
UBS Asset Management Switzerland AGas of 07 May 2024 | 23.37k | 0.41% |
Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024 | 18.83k | 0.33% |
OFZL AGas of 31 Mar 2023 | 10.00k | 0.18% |
CATAM Asset Management AGas of 31 Mar 2021 | 8.00k | 0.14% |
Pictet Asset Management SAas of 31 Jan 2024 | 5.97k | 0.11% |
BlackRock Asset Management Schweiz AGas of 08 May 2024 | 5.47k | 0.10% |
Credit Suisse AGas of 31 Jan 2024 | 3.41k | 0.06% |
Gutmann Finanz Strategien AGas of 31 Mar 2024 | 2.05k | 0.04% |
Lombard Odier Asset Management (Switzerland) SAas of 29 Mar 2024 | 1.37k | 0.02% |
More ▼
Data from 31 Mar 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.